Shingles Vaccine Linked to Reduced Risk of Heart Disease and Dementia

A new study presented at IDWeek reveals that the shingles vaccine significantly reduces the risk of heart disease, dementia, and death among adults aged 50 and older.

Research presented in Atlanta on October 20, 2025, indicates that the shingles vaccine can reduce the risk of dementia and stroke in adults aged 50 and older.
The study highlights the vaccines role in preventing complications beyond the rash associated with shingles, emphasizing its importance in overall health management for older adults.
The connection between the virus that causes shingles and serious health issues like heart disease underlines the need for vaccination to prevent infection and associated risks.

Why It Matters

Understanding the broader health benefits of the shingles vaccine could encourage more adults to get vaccinated, potentially leading to lower rates of dementia and heart-related illnesses in the aging population.